Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review. TMJGM. 2024;1(1):1-16. Accessed November 4, 2026. https://medicaljournalinternational.org/tmjgm/article/view/1